Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protopic for Maintenance in Non-Segmental Vitiligo
NCT01841008Phase 3Terminated
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Dec 2011
- Primary completion
- Jun 2013
- Countries
- 1
01
Overview
A Phase 3 trial of Envarsus XR in nonsegmental vitiligo (NSV), sponsored by Centre Hospitalier Universitaire de Nice. Started Dec 2011; status: terminated.
02
Drugs
Envarsus XR
03
Conditions
nonsegmental vitiligo (NSV)
Beyond the preview
Go deeper on NCT01841008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01841008.